|
1
|
Dawsey SP, Tonui S, Parker RK, Fitzwater
JW, Dawsey SM, White RE and Abnet CC: Esophageal cancer in young
people: A case series of 109 cases and review of the literature.
PLoS One. 5:e140802010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Siegel R, Ward E, Brawley O and Jemal A:
Cancer statistics, 2011: The impact of eliminating socioeconomic
and racial disparities on premature cancer deaths. CA Cancer J
Clin. 61:212–236. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ando N, Ozawa S, Kitagawa Y, Shinozawa Y
and Kitajima M: Improvement in the results of surgical treatment of
advanced squamous esophageal carcinoma during 15 consecutive years.
Ann Surg. 232:225–232. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Strong VE, D'Amico TA, Kleinberg L and
Ajani J: Impact of the 7th Edition AJCC staging classification on
the NCCN clinical practice guidelines in oncology for gastric and
esophageal cancers. J Natl Compr Canc Netw. 11:60–66.
2013.PubMed/NCBI
|
|
5
|
Iwase H, Shimada M, Tsuzuki T, Hirashima
N, Okeya M, Hibino Y, Ryuge N, Yokoi M, Kida Y, Kuno T, et al:
Concurrent chemoradiotherapy with a novel fluoropyrimidine, S-1 and
cisplatin for locally advanced esophageal cancer: Long-term results
of a phase II trial. Oncology. 84:342–349. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zhao L, Guo QL, You QD, Wu ZQ and Gu HY:
Gambogic acid induces apoptosis and regulates expressions of Bax
and Bcl-2 protein in human gastric carcinoma MGC-803 cells. Biol
Pharm Bull. 27:998–1003. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Gu H, Rao S, Zhao J, Wang J, Mu R, Rong J,
Tao L, Qi Q, You Q and Guo Q: Gambogic acid reduced bcl-2
expression via p53 in human breast MCF-7 cancer cells. J Cancer Res
Clin Oncol. 135:1777–1782. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Xie H, Qin YX, Zhou YL, Tong LJ, Lin LP,
Geng MY, Duan WH and Ding J: GA3, a new gambogic acid derivative,
exhibits potent antitumor activities in vitro via
apoptosis-involved mechanisms. Acta Pharmacol Sin. 30:346–354.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Guo QL, You QD, Wu ZQ, Yuan ST and Zhao L:
General gambogic acids inhibited growth of human hepatoma SMMC-7721
cells in vitro and in nude mice. Acta Pharmacol Sin.
25:769–774. 2004.PubMed/NCBI
|
|
10
|
Colo GP, Rubio MF, Nojek IM, Werbajh SE,
Echeverría PC, Alvarado CV, Nahmod VE, Galigniana MD and Costas MA:
The p160 nuclear receptor co-activator RAC3 exerts an
anti-apoptotic role through a cytoplasmatic action. Oncogene.
27:2430–2444. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Nicholson DW and Thornberry NA: Caspases:
Killer proteases. Trends Biochem Sci. 22:299–306. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Savill J and Fadok VA: Corpse clearance
defines the meaning of cell death. Nature. 407:784–788. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Danial NN and Korsmeyer SJ: Cell death:
Critical control points. Cell. 116:205–219. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Gu HY, Guo QL, You QD, Liu W, Qi Q, Li Z,
Yuan ST and Zhang K: Gambogic acid inducing apoptosis in human
hepatoma SMMC-7721 cells with p53 and Bax up-regulated. Chin J Nat
Med. 3:169–171. 2005.
|
|
15
|
Xu J, Zhou M, Ouyang J, Wang J, Zhang Q,
Xu Y, Xu Y, Zhang Q, Xu X and Zeng H: Gambogic acid induces
mitochondria-dependent apoptosis by modulation of Bcl-2 and Bax in
mantle cell lymphoma JeKo-1 cells. Zhongguo Aizheng Yanjiu
(Yingwenban). 25:183–191. 2013.
|
|
16
|
Luo GX, Cai J, Lin JZ, Luo WS, Luo HS,
Jiang YY and Zhang Y: Autophagy inhibition promotes gambogic
acid-induced suppression of growth and apoptosis in glioblastoma
cells. Asian Pac J Cancer Prev. 13:6211–6216. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Shi SQ and Cao HM: Shikonin promotes
autophagy in BXPC-3 human pancreatic cancer cells through the
PI3K/Akt signaling pathway. Oncol Lett. 8:1087–1089.
2014.PubMed/NCBI
|
|
18
|
Zhang BC: Treatment of symptoms and root
causes of disease-management of the top ten symptoms in cancer
patients. Fang Ai Tian Di. 20:17–18. 2007.
|
|
19
|
Smith ME and Bauer-Wu S: Traditional
Chinese Medicine for cancer-related symptoms. Semin Oncol Nurs.
28:64–97. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wang S, Wu X, Tan M, Gong J, Tan W, Bian
B, Chen M and Wang Y: Fighting fire with fire: Poisonous Chinese
herbal medicine for cancer therapy. J Ethnopharmacol. 140:33–45.
2012. View Article : Google Scholar : PubMed/NCBI
|
